A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
Clinical trial NCT04927481 · TERMINATED
Trial details
- NCT number
- NCT04927481
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2023-01-17
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.